News | October 19, 2023
Evonik launches Eudracap preclinic functional oral capsule for preclinical trials
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
US FDA approval is in line with de-risking strategy for additional API site to service our global customer base
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
The maker of ivermectin/pyrantel, the #1 vet-recommended and #1 dog-preferred real beef chew introduces the latest innovation in its portfolio
The two-part production system is proven to yield high-quality proteins from GS-CHO cell lines, a prevalent mammalian host cell for protein production
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Cipla has a robust governance model focused on sustainability
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
Convergent action on AMR identified as an important area of intervention
Subscribe To Our Newsletter & Stay Updated
